Brian Harvey - Genasys Director Markets
| GNSS Stock | USD 3.77 0.05 1.34% |
Insider
Brian Harvey is Director Markets of Genasys
| Address | 16262 West Bernardo Drive, San Diego, CA, United States, 92127 |
| Phone | 858 676 1112 |
| Web | https://genasys.com |
Genasys Management Efficiency
The company has return on total asset (ROA) of (0.2312) % which means that it has lost $0.2312 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8439) %, meaning that it created substantial loss on money invested by shareholders. Genasys' management efficiency ratios could be used to measure how well Genasys manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.56 in 2024. Return On Capital Employed is likely to drop to -0.27 in 2024. At this time, Genasys' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 29.8 M in 2024, whereas Total Current Assets are likely to drop slightly above 19.4 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Daniel Comas | Fortive Corp | 56 | |
| Read Simmons | Fortive Corp | N/A | |
| Chuck Ravetto | Novanta | N/A | |
| Liqun Han | Cepton Inc | 55 | |
| Edward Simmons | Fortive Corp | 50 | |
| Deborah Boniske | ESCO Technologies | N/A | |
| Rebecca Dunn | Spectris plc | N/A | |
| Simon Pontin | Itron Inc | N/A | |
| MSc MA | Spectris plc | 60 | |
| Steven Cantor | Vishay Precision Group | N/A | |
| Steven Kent | Know Labs | N/A | |
| Sarah Betadam | Novanta | N/A | |
| Sharmistha Dubey | Fortive Corp | 50 | |
| Dongyi Liao | Cepton Inc | 48 | |
| Sejal Gulati | Vishay Precision Group | N/A | |
| Hull Xu | Cepton Inc | 50 | |
| Rejji Hayes | Fortive Corp | 46 | |
| Ronald JD | Know Labs | 80 | |
| Winston Fu | Cepton Inc | 55 | |
| Wright Lassiter | Fortive Corp | N/A | |
| David Schatz | ESCO Technologies | 60 | |
Management Performance
| Return On Equity | -0.84 | ||||
| Return On Asset | -0.23 |
Genasys Leadership Team
Elected by the shareholders, the Genasys' board of directors comprises two types of representatives: Genasys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genasys. The board's role is to monitor Genasys' management team and ensure that shareholders' interests are well served. Genasys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genasys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karen Bowling, VP Marketing | ||
| Satya Chillara, Investor Officer | ||
| Dennis Klahn, CFO Secretary | ||
| Brian Harvey, Director Markets | ||
| Brian CFA, Senior Development | ||
| Dennis Walsh, Chief Officer | ||
| Richard Danforth, CEO Director |
Genasys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genasys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.84 | ||||
| Return On Asset | -0.23 | ||||
| Profit Margin | (1.09) % | ||||
| Operating Margin | (0.75) % | ||||
| Current Valuation | 171.68 M | ||||
| Shares Outstanding | 44.6 M | ||||
| Shares Owned By Insiders | 3.81 % | ||||
| Shares Owned By Institutions | 52.56 % | ||||
| Number Of Shares Shorted | 692.07 K | ||||
| Price To Earning | 158.50 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Genasys Stock Analysis
When running Genasys' price analysis, check to measure Genasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genasys is operating at the current time. Most of Genasys' value examination focuses on studying past and present price action to predict the probability of Genasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genasys' price. Additionally, you may evaluate how the addition of Genasys to your portfolios can decrease your overall portfolio volatility.